- Home
- ETON vs KOSS Comparison
ETON vs KOSS Comparison
Compare ETON & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- KOSS
- Stock Information
- Founded
- ETON 2017
- KOSS 1953
- Country
- ETON United States
- KOSS United States
- Employees
- ETON N/A
- KOSS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- KOSS Consumer Electronics/Appliances
- Sector
- ETON Health Care
- KOSS Consumer Staples
- Exchange
- ETON Nasdaq
- KOSS Nasdaq
- Market Cap
- ETON 388.3M
- KOSS 57.5M
- IPO Year
- ETON 2018
- KOSS N/A
- Fundamental
- Price
- ETON $17.98
- KOSS $5.79
- Analyst Decision
- ETON Strong Buy
- KOSS
- Analyst Count
- ETON 3
- KOSS 0
- Target Price
- ETON $29.67
- KOSS N/A
- AVG Volume (30 Days)
- ETON 227.6K
- KOSS 77.2K
- Earning Date
- ETON 11-11-2025
- KOSS 10-30-2025
- Dividend Yield
- ETON N/A
- KOSS N/A
- EPS Growth
- ETON N/A
- KOSS N/A
- EPS
- ETON N/A
- KOSS N/A
- Revenue
- ETON $58,181,000.00
- KOSS $12,624,170.00
- Revenue This Year
- ETON $105.25
- KOSS N/A
- Revenue Next Year
- ETON $40.84
- KOSS N/A
- P/E Ratio
- ETON N/A
- KOSS N/A
- Revenue Growth
- ETON 85.40
- KOSS 2.93
- 52 Week Low
- ETON $4.79
- KOSS $4.00
- 52 Week High
- ETON $21.48
- KOSS $8.59
- Technical
- Relative Strength Index (RSI)
- ETON 63.65
- KOSS 45.90
- Support Level
- ETON $17.22
- KOSS $5.60
- Resistance Level
- ETON $18.06
- KOSS $6.29
- Average True Range (ATR)
- ETON 0.67
- KOSS 0.28
- MACD
- ETON -0.03
- KOSS -0.09
- Stochastic Oscillator
- ETON 70.51
- KOSS 15.20
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.